nazartinib

1508250-71-2

4-Pyridinecarboxamide, N-[7-chloro-1-[(3R)-1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1H-azepin-3-yl]-1H-benzimidazol-2-yl]-2-methyl-

KE7K32EME8

N-(7-Chlor-1-{(3R)-1-[(2E)-4-(dimethylamino)-2-butenoyl]-3-azepanyl}-1H-benzimidazol-2-yl)-2-methylisonicotinamid

N-(7-Chloro-1-{(3R)-1-[(2E)-4-(dimethylamino)-2-butenoyl]-3-azepanyl}-1H-benzimidazol-2-yl)-2-methylisonicotinamide

N-(7-Chloro-1-{(3R)-1-[(2E)-4-(diméthylamino)-2-butenoyl]-3-azépanyl}-1H-benzimidazol-2-yl)-2-méthylisonicotinamide

N-{7-chloro-1-[(3R)-1-[(2E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]-1H-1,3-benzodiazol-2-yl}-2-methylpyridine-4-carboxamide

nazartinib

nazartinib

nazartinib

nazartinibum

назартиниб

نازارتينيب

那扎替尼

(R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide

1-(2-Benzylidenehydrazinyl)phthalazine

compound 47 [PMID: 27433829]

egf-816nazartinib

EGFR_HUMAN

Epidermal growth factor receptor

MFCD28963918

N-[7-chloro-1-[(3R)-1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1H-azepin-3-yl]-1H-benzimidazol-2-yl]-2-methyl-4-pyridinecarboxamide

N-[7-chloro-1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamide

nazartinib (egf816, nvs-816)

nazartinib ;egf816; nvs-816

nazartinib(egf816)

nazartinib;egf816;nvs-816

nazartinibum

назартиниб

نازارتينيب

那扎替尼